Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer's drug candidates.
Leuci R, Simic S, Carrieri A, Chaves S, La Spada G, Brunetti L, Tortorella P, Loiodice F, Laghezza A, Catto M, Santos MA, Tufarelli V, Wackerlig J, Piemontese L.
Leuci R, et al. Among authors: santos ma.
Bioorg Chem. 2024 Oct 18;153:107895. doi: 10.1016/j.bioorg.2024.107895. Online ahead of print.
Bioorg Chem. 2024.
PMID: 39454499
Free article.